EUVIMEDEUVIMED entdecken
Crossref

Ultrasmall Polymeric Micelles Enable Noninvasive Transdermal Rosiglitazone Delivery via Lipid Fluidization and Transcytosis

Yuan Wang, Songmei Luo, Lu Wang, Yansong Zhang, Ruhui Yang iD, Yuhao Jiang, Jingjing Guo, Xingjie Zan, Sicheng Tang iD, Kejun Cheng iD

Biomacromolecules · 2026

DOI: 10.1021/acs.biomac.6c00656 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomacromolecules, 2026. Verfasst von Yuan Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Fuchun Campus, Hangzhou311402, China. Hauptthemen laut MEDLINE: Rosiglitazone, Hypoglycemic Agents, Drug Delivery Systems, Diabetes Mellitus, Type 2. Die Arbeit nennt 54 Literaturangaben. Gefördert von: Zhejiang Chinese Medical University Talent Recruitment Fund, Zhejiang Provincial Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Noninvasive transdermal drug delivery (TDD) offers sustained therapeutic release but is hindered by the stratum corneum (SC) barrier. Herein, we report ultrasmall polymeric micelles (PMs) embedded in poly(vinyl alcohol) hydrogels for the passive TDD of rosiglitazone (RGT) to treat Type 2 diabetes mellitus (T2DM). We synthesized amphiphilic brush copolymers with varied hydrophobic cores (linear alkanes, benzene, borneol) to tune SC interactions and ensure colloidal stability. Ex vivo murine skin studies demonstrated that PM variants with C10 alkane and benzene cores achieved 10.56% and 19.84% cumulative permeation at 24 h, respectively, via dual paracellular/intracellular routes. In vivo, PM hydrogels delivered steady plasma accumulation. In a T2DM model, transdermal RGT reduced blood glucose by 30% over 12 days without observable skin or organ toxicity. This nanoplatform enables noninvasive systemic delivery, offering a robust alternative to oral administration for sustained glycemic control.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RosiglitazoneHypoglycemic AgentsDrug Delivery SystemsDiabetes Mellitus, Type 2PolymersAnimalsMicellesAdministration, CutaneousMiceTranscytosisSkinHydrogelsLipids

Substanzen

MicellesRosiglitazoneHypoglycemic AgentsPolymersHydrogelsLipids

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Fuchun Campus, Hangzhou311402, China.
  • University of the Chinese Academy of Sciences Wenzhou Institute , Wenzhou325001, China.
  • Department of Pharmacy, Lishui Central Hospital, The Fifth Hospital Affiliated to Wenzhou Medical University, Lishui323000, China.
  • Optometry and Ophthalmology Clinic, Suzhou Kowloon Hospital, Shanghai Jiao Tong University School of Medicine, Suzhou21500, China.
  • College of Life and Environmental Science, Wenzhou University, Wenzhou325005, China.

ORCID-Profile: Ruhui Yang, Sicheng Tang, Kejun Cheng

Förderung

  • Zhejiang Chinese Medical University Talent Recruitment Fund
  • Zhejiang Provincial Natural Science Foundation of China

Zitieren

APA

Wang, Y., Luo, S., Wang, L., Zhang, Y., Yang, R., Jiang, Y., Guo, J., Zan, X., Tang, S., & Cheng, K. (2026). Ultrasmall Polymeric Micelles Enable Noninvasive Transdermal Rosiglitazone Delivery via Lipid Fluidization and Transcytosis. Biomacromolecules. https://doi.org/10.1021/acs.biomac.6c00656

Vancouver

Wang Y, Luo S, Wang L, Zhang Y, Yang R, Jiang Y, et al. Ultrasmall Polymeric Micelles Enable Noninvasive Transdermal Rosiglitazone Delivery via Lipid Fluidization and Transcytosis. Biomacromolecules. 2026. doi:10.1021/acs.biomac.6c00656

BibTeX
@article{Wang2026,
  author = {Wang, Yuan and Luo, Songmei and Wang, Lu and Zhang, Yansong and Yang, Ruhui and Jiang, Yuhao and Guo, Jingjing and Zan, Xingjie and Tang, Sicheng and Cheng, Kejun},
  title = {Ultrasmall Polymeric Micelles Enable Noninvasive Transdermal Rosiglitazone Delivery via Lipid Fluidization and Transcytosis},
  journal = {Biomacromolecules},
  year = {2026},
  doi = {10.1021/acs.biomac.6c00656}
}
Kostenlos starten →